- Profile
- Personal Information
- Publications
Experts in Dermatology
Wei Huachen Wong Mun Loke Crystal Ugochi Aguh Mübeccel Akdis Donald V. Belsito Robert R. Walther Ellen A. Lumpkin Julian M. Mackay-Wiggan David M. Owens Angela Christiano Faramarz Samie Larisa J Geskin Chhanda Dutta Ashwini Rani SR Dr. Kushalappa P.A Dr. Veeranna S Dr. Jaydev B. Betkerur Dr. Kanthraj G.R. Dr. Ashwani P.K Dr. Ranugha P.S.S. View MoreTony Radford was the co-founder and CEO of Cellestis which developed and commercialised QuantiFERON Gold, for diagnosis of tuberculosis infection. Cellestis listed on the ASX and was acquired by QIAGEN NV in 2011 for approximately $400M. Tony has a PhD from La Trobe University, and was awarded an Order of Australia for distinguished service to science and global public health. Tony is a director of Genetic Signalures (ASX: GSS). BACK
Tony Radford was the co-founder and CEO of Cellestis which developed and commercialised QuantiFERON Gold, for diagnosis of tuberculosis infection. Cellestis listed on the ASX and was acquired by QIAGEN NV in 2011 for approximately $400M. Tony has a PhD from La Trobe University, and was awarded an Order of Australia for distinguished service to science and global public health. Tony is a director of Genetic Signalures (ASX: GSS). BACK